Menu
 
Research menu
Jump to menu

Publications:  Dr Paul Telfer

Maggio A, Kattamis A, Felisi M, Reggiardo G, El-Beshlawy A, Bejaoui M, Sherief L, Christou S et al.(2020). Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Lancet Haematol vol. 7, (6) e469-e478.
10.1016/S2352-3026(20)30100-9
Roy NBA, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F, Roberts D, Atoyebi W et al.(2020). Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. British Journal of Haematology vol. 189, (4) 635-639.
10.1111/bjh.16687
DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P et al.(2020). American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv vol. 4, (8) 1554-1588.
10.1182/bloodadvances.2019001142
Oakley LL, Awogbade M, Brien S, Briley A, Chorozoglou M, Drasar E, Johns J, Rhodes E et al.(2020). Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial. Trials vol. 21, (1)
10.1186/s13063-020-4212-8
Sangarappillai C, Soriano M, Telfer P, Newell K, Amoh I, Halbert J, Ndifor N, Kaya B et al. (2020). Hydroxyurea therapy does not impact TCD velocity in the East London sickle cell newborn cohort study. BRITISH JOURNAL OF HAEMATOLOGY. vol. 189, 146-147.
Booth CS, Barroso F, Bennett S, Kafuko D, Telfer P, Kaya B (2020). Rh antibodies in patients with sickle cell disease - an on-going challenge. BRITISH JOURNAL OF HAEMATOLOGY. vol. 189, 166-166.
Hossain MS, Hasan MM, Raheem E, Islam MS, Al Mosabbir A, Petrou M, Telfer P, Siddiqee MH(2020). Lack of knowledge and misperceptions about thalassaemia among college students in Bangladesh: A cross-sectional baseline study. Orphanet Journal of Rare Diseases vol. 15, (1)
10.1186/s13023-020-1323-y
Renedo A, Miles S, Chakravorty S, Leigh A, Telfer P, Warner JO, Marston C(2019). Not being heard: barriers to high quality unplanned hospital care during young people's transition to adult services - evidence from 'this sickle cell life' research. BMC Health Serv Res vol. 19, (1)
10.1186/s12913-019-4726-5
Brown RA, Moon JC, Telfer PT, Khanji MY(2019). Extreme cardiac iron loading in transfusion-dependent thalassaemia major: cardiac T2* and T1 mapping guiding treatment. Eur Heart J vol. 40, (43)
10.1093/eurheartj/ehz137
Ryan K, Pancham S, Telfer P, Shah F, Kell J, Pollard S, Wynn R, Velangi M et al. (2019). HEALTH-RELATED QUALITY OF LIFE AND PRODUCTIVITY/ACTIVITY IMPAIRMENT IN PATIENTS WITH TRANSFUSION DEPENDENT B-THALASSAEMIA IN THE UK NHS: DATA FROM A UK MULTICENTRE OBSERVATIONAL STUDY. VALUE IN HEALTH. vol. 22, S868-S869.
Telfer P, Barroso F, Newell K, Challands J, Kaya B(2019). Evaluation of a Non-Parenteral Opioid Analgesia Protocol for Acute Sickle Cell Pain Episodes in Children. J Clin Med vol. 8, (10)
10.3390/jcm8101728
Elander J, Bij D, Kapadi R, Schofield MB, Osias A, Khalid N, Kaya B, Telfer P (2019). Development and validation of the Satisfaction with Treatment for Pain Questionnaire (STPQ) among patients with sickle cell disease. British Journal of Haematology. vol. 187, 105-116.
10.1111/bjh.16015
Downes M, de Haan M, Telfer PT, Kirkham FJ(2019). The Role of Family Functioning in the Development of Executive Functions in Preschool Children with Sickle Cell Anemia. Dev Neuropsychol vol. 44, (6) 452-467.
10.1080/87565641.2019.1660779
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM et al.(2019). A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med vol. 381, (6) 509-519.
10.1056/NEJMoa1903212
Cooper O, McBain H, Tangayi S, Telfer P, Tsitsikas D, Yardumian A, Mulligan K(2019). Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population. Health Qual Life Outcomes vol. 17, (1)
10.1186/s12955-019-1136-7
Howard J, Hemmaway CJ, Telfer P, Layton DM, Porter J, Awogbade M, Mant T, Gretler DD et al.(2019). A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease. Blood vol. 133, (17) 1865-1875.
10.1182/blood-2018-08-868893
Mecci J, Maxan M-E, Kemos P, Telfer P, Barroso F, Foster G, Banu K (2019). Diagnosis of sickle cell liver disease may be aided by non-invasive tests. JOURNAL OF HEPATOLOGY. vol. 70, E586-E587.
10.1016/S0618-8278(19)31174-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64896
Telfer P, Kaya B, Barroso F, Nzouakou R, Osias A, Bloom B, Skene I, Boulton O et al. (2019). A Phase 1 study to determine maximum tolerated dose of sublingual fentanyl in combination with oral oxycodone for hospital management of an acute painful crisis in adolescents and adults with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 185, 113-114.
Ryan K, Pancham S, Telfer P, Shah F, Kell J, Pollard S, Wynn R, Velangi M et al. (2019). An observational study to evaluate the routine management, healthcare resource use and outcomes for patients with transfusion-dependent beta-thalassaemia treated in the United Kingdom: an interim analysis. BRITISH JOURNAL OF HAEMATOLOGY. vol. 185, 114-115.
Mckinnon K, Telfer P, Kaya B (2019). Causes, management and outcomes of extreme paediatric thrombocytosis. BRITISH JOURNAL OF HAEMATOLOGY. vol. 185, 108-108.
Sangarappillai C, Kaya B, Barroso F, Telfer P (2019). Patients lost to follow-up in the East London Newborn Sickle Cell Cohort Study. BRITISH JOURNAL OF HAEMATOLOGY. vol. 185, 123-124.
Okochi J, Tsiagbe M, Joseph W, James J, Osmond-Joseph K, Telfer P, Barroso F, Kaya B (2019). Peer to peer mentoring for patients with Sickle Cell Disease - interim analysis of results from a pilot programme in East London. BRITISH JOURNAL OF HAEMATOLOGY. vol. 185, 116-116.
Casella JF, Adams RJ, Brambilla DJ, Strouse JJ, Maier P, Dlugash R, Avadhani R, Vermillion K et al.(2019). Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials vol. 16, (1) 20-31.
10.1177/1740774518807160
Downes M, Kirkham FJ, Berg C, Telfer P, de Haan M(2019). Executive performance on the preschool executive task assessment in children with sickle cell anemia and matched controls. Child Neuropsychol vol. 25, (2) 278-285.
10.1080/09297049.2018.1491962
Downes M, de Haan M, O'Leary T, Telfer PT, Kirkham FJ(2018). Temperament in preschool children with sickle cell anaemia. Arch Dis Child
10.1136/archdischild-2018-315054
Vichinsky E, Hoppe C, Howard J, Ataga KI, Nduba V, El-Beshlawy A, Diuguid DL, Al-Kindi S et al. (2018). Results from Part A of the Hemoglobin Oxygen Affinity Modulation to Inhibit HbS Polymerization (HOPE) Trial (GBT440-031), a Placebo-Controlled Randomized Study Evaluating Voxelotor (GBT440) in Adults and Adolescents with Sickle Cell Disease. BLOOD. vol. 132,
10.1182/blood-2018-99-118508
Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Backman Johansson C, Badens C, Bento C et al.(2018). Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. Br J Haematol vol. 183, (4) 648-660.
10.1111/bjh.15600
Downes M, Kirkham FJ, Telfer PT, de Haan M(2018). Assessment of Executive Functions in Preschool Children With Sickle Cell Anemia. J Int Neuropsychol Soc vol. 24, (9) 949-954.
10.1017/S1355617718000255
Downes M, Kirkham FJ, Telfer PT, de Haan M(2018). Altered Neurophysiological Processing of Auditory Attention in Preschool Children With Sickle Cell Disease. J Pediatr Psychol vol. 43, (8) 856-869.
10.1093/jpepsy/jsx115
Telfer P, Agodoa I, Fox KM, Burke L, Mant T, Jurek M, Tonda M, Lehrer-Graiwer J(2018). Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease: A patient case report. Hematology Reports vol. 10, (2) 1-6.
10.4081/hr.2018.7643
Yeo JH, Islam A, Cavenagh J, Smith M, Telfer P, Kaya B (2018). A Case Report of Dehydrated Hereditary Stomatocytosis and Spherocytosis. BRITISH JOURNAL OF HAEMATOLOGY. vol. 181, 125-125.
Nzouakou R, Kaya B, Koomson E, Barroso F, Telfer P (2018). Cross-over study comparing manual exchange transfusion versus automated erythrocytapheresis. Experience of a single centre. BRITISH JOURNAL OF HAEMATOLOGY. vol. 181, 122-122.
Smith C, Kawadler J, Kirkham F, Hogan A, Telfer P, Stotesbury H (2018). Residential proximity to major roads and cognitive function in asymptomatic children with Sickle Cell Anaemia: a longitudinal study. BRITISH JOURNAL OF HAEMATOLOGY. vol. 181, 117-117.
Telfer P, Kaya B(2017). Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease. Hematology Am Soc Hematol Educ Program vol. 2017, (1) 525-533.
10.1182/asheducation-2017.1.525
de Montalembert M, Brousse V, Chakravorty S, Pagliuca A, Porter J, Telfer P, Vora A, Rees DC(2017). Are the risks of treatment to cure a child with severe sickle cell disease too high?. BMJ vol. 359,
10.1136/bmj.j5250
Fisher AE, Oduro AKY, Adzaku F, Telfer P(2017). Presentations of sickle cell disease patients to hospital in Ghana: key findings from a preliminary study at Volta Regional Hospital. Br J Haematol vol. 178, (3) 489-491.
10.1111/bjh.14154
Downes M, de Haan M, Kirkham FJ, Telfer PT(2017). Parent reported sleep problems in preschool children with sickle cell anemia and controls in East London. Pediatr Blood Cancer vol. 64, (6)
10.1002/pbc.26337
Lehrer-Graiwer J, Howard J, Hemmaway CJ, Awogbade M, Telfer P, Layton M, Porter JB, Mant T et al. (2016). Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor. BLOOD. vol. 128,
10.1182/blood.V128.22.2488.2488
Piel FB, Tewari S, Brousse V, Analitis A, Font A, Menzel S, Chakravorty S, Thein SL et al.(2016). Associations between environmental factors and hospital admissions for sickle cell disease. Haematologica vol. 102, (4) 666-675.
10.3324/haematol.2016.154245
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34863
Telfer P, Dwan K, Simmons A, Evanson J, Gadong N, Newell K, Tangayi S, Leigh A et al.(2016). Transcranial Doppler Screening in a Regional Care Network for Sickle Cell Disease in the United Kingdom. J Pediatr Hematol Oncol vol. 38, (7) 517-524.
10.1097/MPH.0000000000000633
Tewari S, Piel F, Brousse V, Analitis A, Ghersi V, Menzel S, Chakravorty S, Inusa B et al. (2016). ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND HOSPITAL ADMISSIONS FOR SICKLE CELL DISEASE: A RETROSPECTIVE TIME SERIES ANALYSIS. HAEMATOLOGICA. vol. 101, 127-128.
Lehrer-Graiwer J, Hemmaway C, Howard J, Telfer P, Layton M, Awogbade M, Porter J, Roberts-Harewood M et al. (2016). GBT440, A NOVEL HBS POLYMERIZATION INHIBITOR, INCREASES HB OXYGEN AFFINITY AND RESULTS IN A RAPID IMPROVEMENT IN HEMOLYSIS AND ANEMIA. HAEMATOLOGICA. vol. 101, 125-125.
Nzouakou R, Newell K, Barroso F, Telfer P, Kaya B (2016). Annual review of transfusion targets in regularly transfused paediatric and adult sickle cell patients. Experiences from Bart's Health NHS Trust. BRITISH JOURNAL OF HAEMATOLOGY. vol. 173, 153-154.
Parhar K, Parizkova B, Jones N, Valchanov K, Fowles J-A, Besser M, Telfer P, Kaya B et al.(2016). Extracorporeal membrane oxygenation for the treatment of adult sickle cell acute chest syndrome. Perfusion vol. 31, (3) 262-265.
10.1177/0267659115593172
Kaya B, Telfer P (2016). Review of an internal quality assurance programme for transcranial doppler (TCD) screening in children with sickle cell disease. Experiences from Bart's Health NHS Trust. BRITISH JOURNAL OF HAEMATOLOGY. vol. 173, 143-143.
Lehrer-Graiwer J, Howard J, Hemmaway CJ, Awogbade M, Telfer P, Layton M, Mant T, Dufu K et al. (2015). GBT440, a Potent Anti-Sickling Hemoglobin Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells in Peripheral Blood of Patients with Sickle Cell Disease. BLOOD. vol. 126,
10.1182/blood.V126.23.542.542
de la Fuente J, O'Boyle F, Harrington Y, Bradshaw A, Hind S, Chakravorty S, Karnik L, New H et al. (2015). Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach Is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation. BLOOD. vol. 126,
Badat M, Kaya B, Telfer P(2015). Combination-therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron-loading in aceruloplasminaemia. Br J Haematol vol. 171, (3) 430-432.
10.1111/bjh.13401
De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A et al.(2015). 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Pediatr Blood Cancer vol. 62, (8) 1427-1436.
10.1002/pbc.25502
Kawadler JM, Kirkham FJ, Clayden JD, Hollocks MJ, Seymour EL, Edey R, Telfer P, Robins A et al.(2015). White Matter Damage Relates to Oxygen Saturation in Children With Sickle Cell Anemia Without Silent Cerebral Infarcts. Stroke vol. 46, (7) 1793-1799.
10.1161/STROKEAHA.115.008721
Tsouana E, Kaya B, Gadong N, Hemmaway C, Newell H, Simmons A, Whitmarsh S, Telfer P(2015). Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network. Eur J Haematol vol. 94, (4) 336-342.
10.1111/ejh.12435
Badat M, Bailey F, Syed T, Badle S, Simmons A, Kaya B, Telfer P (2015). Effects of the 2013 MHRA update on codeine use: a retrospective study of admissions to hospital with an acute vaso-occlusive pain crisis in children with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 169, 99-99.
Telfer P, Simmons A, Gadong N, Newell K, Tangayi S, Leigh A, Vaidyanathan S, Hemmaway C et al. (2015). Transcranial Doppler screening and residual stroke rate in UK children with sickle cell disease: data from the East London and Essex clinical haemoglobinopathy network. BRITISH JOURNAL OF HAEMATOLOGY. vol. 169, 23-23.
Fisher AE, Oduro AKY, Adzaku FK, Telfer P (2015). Use of analgesia in sickle cell crisis at Volta Regional Hospital, Ho, Ghana. BRITISH JOURNAL OF HAEMATOLOGY. vol. 169, 101-101.
de la Fuente J, Harrington Y, Bradshaw A, Inusa B, Telfer P (2015). Parental Haploidentical HSCT with a Post-Infusion of Stem Cells Cyclophosphamide Approach is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation. BONE MARROW TRANSPLANTATION. vol. 50, S45-S45.
Kuo KHM, Ward R, Kaya B, Howard J, Telfer P(2015). A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients. British Journal of Haematology vol. 170, (3) 425-428.
10.1111/bjh.13294
Tewari S, Piel F, Brousse V, Inusa BPD, Telfer P, Menzel S, De Montalembert M, Gardner K et al. (2014). A Multicentre Study of Environmental Factors on the Severity of Sickle Cell Disease. BLOOD. vol. 124,
Calvaruso G, Vitrano A, Di Maggio R, Ballas S, Steinberg MH, Rigano P, Sacco M, Telfer P et al.(2014). Deferiprone versus deferoxamine in sickle cell disease: results from a 5-year long-term Italian multi-center randomized clinical trial. Blood Cells Mol Dis vol. 53, (4) 265-271.
10.1016/j.bcmd.2014.04.004
DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH et al.(2014). Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med vol. 371, (8) 699-710.
10.1056/NEJMoa1401731
Telfer P, Bahal N, Lo A, Challands J(2014). Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients. Br J Haematol vol. 166, (2) 157-164.
10.1111/bjh.12879
Hogan AM, Telfer PT, Kirkham FJ, de Haan M(2013). Precursors of Executive Function in Infants With Sickle Cell Anemia. JOURNAL OF CHILD NEUROLOGY vol. 28, (10) 1197-1202.
10.1177/0883073812453495
Maggio A, Vitrano A, Calvaruso G, Barone R, Rigano P, Mancuso L, Cuccia L, Capra M et al.(2013). Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death. BLOOD CELLS MOLECULES AND DISEASES vol. 50, (4) 241-246.
10.1016/j.bcmd.2012.12.002
Lagunju I, Sodeinde O, Telfer P(2012). Prevalence of transcranial Doppler abnormalities in Nigerian children with sickle cell disease. AMERICAN JOURNAL OF HEMATOLOGY vol. 87, (5) 544-547.
10.1002/ajh.23152
DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT et al.(2012). Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. BLOOD vol. 119, (16) 3684-3690.
10.1182/blood-2011-05-349621
Telfer P, Dundas I, Rae J, Toweh G, Kaya B, Newell K, Pao C, Grigg J et al. (2012). A cohort study of sleep disordered breathing in preschool children with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 157, 70-71.
Mohamed M, Pratt R, Telfer P, Kaya B (2012). Acute pain management protocols in adult sickle cell patients - audit of observation frequency following administration of opiate analgesia. BRITISH JOURNAL OF HAEMATOLOGY. vol. 157, 74-75.
Jayaratne D, Wirth L, Barber C, Kaya B, Telfer P, Allard S (2012). Alloantibody formation in regularly transfused young patients (aged <= 21 years) with sickle cell disease - a single centre review. BRITISH JOURNAL OF HAEMATOLOGY. vol. 157, 82-82.
Mohamed M, Pratt R, Telfer P, Kaya B (2012). Use of individualised acute pain management protocols in adult sickle cell patients - a single centre experience. BRITISH JOURNAL OF HAEMATOLOGY. vol. 157, 75-75.
Telfer PT, Evanson J, Butler P, Hemmaway C, Abdulla C, Gadong N, Whitmarsh S, Kaya B et al.(2011). Cervical carotid artery disease in sickle cell anemia: clinical and radiological features. Blood vol. 118, (23) 6192-6199.
10.1182/blood-2011-03-337915
Obaro SK, Inusa B, Telfer P(2011). Hydroxycarbamide use in young children with sickle-cell anaemia. LANCET vol. 378, (9805) 1777-1777.
10.1016/S0140-6736(11)61770-4
Kaur M, Sen G, Kaya B, Telfer P (2011). An audit of a transfusion algorithm for use in paediatric thalassaemia patients. BRITISH JOURNAL OF HAEMATOLOGY. vol. 153, 66-67.
Telfer PT, Evanson J, Hemmaway C, Abdullah C, Gadong N, Whitmarsh S, van Meijgaarden B, Kaya B et al. (2011). Low risk of stroke in children with sickle cell disease (SCD) screened with transcranial Doppler (TCD) ultrasound. BRITISH JOURNAL OF HAEMATOLOGY. vol. 153, 26-27.
Leigh AY, Nolan A, Cryer J, Lethaby D, Doukrou M, Fulcher S, Kaya B, Simmons A et al. (2011). Percutaneous endoscopic gastrostomy feeds in children with sickle cell disease and growth failure; a novel approach with high patient and carer satisfaction. BRITISH JOURNAL OF HAEMATOLOGY. vol. 153, 65-65.
Di Marco V, Capra M, Angelucci E, Borgna-Pignatti C, Telfer P, Harmatz P, Kattamis A, Prossamariti L et al.(2010). Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. BLOOD vol. 116, (16) 2875-2883.
10.1182/blood-2009-11-248724
Telfer PT, Warburton F, Christou S, Hadjigavriel M, Sitarou M, Kolnagou A, Angastiniotis M(2009). Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone. Haematologica vol. 94, (12) 1777-1778.
10.3324/haematol.2009.009118
Telfer P, Criddle J, Sandell J, Davies F, Morrison I, Challands J(2009). Intranasal diamorphine for acute sickle cell pain. Arch Dis Child vol. 94, (12) 979-980.
10.1136/adc.2008.138875
Sarnaik SA, Casella JF, Barton BA, Afif M, Airewele G, Berman BW, Bernaudin F, Coates T et al. (2009). Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia. BLOOD. vol. 114, 111-111.
10.1182/blood.V114.22.262.262
Kaya B, Heath P, Vaidya M, Telfer P (2009). A role for non invasive ventilation for acute chest syndrome in children: our experience. BRITISH JOURNAL OF HAEMATOLOGY. vol. 145, 73-73.
Telfer P(2009). Update on survival in thalassemia major. Hemoglobin vol. 33 Suppl 1, S76-S80.
10.3109/03630260903347336
Tsitsikas DA, Barroso FA, Telfer P, Kaya B, Evanson J, Provan A(2008). A patient with beta thalassaemia major and back pain. BMJ vol. 337,
10.1136/bmj.a2304
King MJ, Telfer P, MacKinnon H, Langabeer L, McMahon C, Darbyshire P, Dhermy D(2008). Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. CYTOM PART B-CLIN CY vol. 74B, (4) 244-250.
10.1002/cyto.b.20413
Kirkham J, Baird J, Telfer P, Khatura J, Sahota TP, Wilkey O, Robins A, Morgan MA et al. (2008). HEIGHT AND WEIGHT IN A UK POPULATION OF CHILDREN WITH SICKLE CELL DISEASE. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 448-448.
Kirkham J, Telfer P, Bucks RS, Hewes DKM, Kaya B, Prengler M, Dundas I, Lane R et al. (2008). OVERNIGHT OXYHAEMOGLOBIN DESATURATION PREDICTS ABNORMAL TRANSCRANIAL DOPPLER IN SICKLE CELL ANAEMIA. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 252-252.
Kirkham J, Dingle-Gavlak J, Krings J, Hewes DKM, Dundas I, Lane R, Carr S, Evans JPM et al. (2008). OXYHAEMOGLOBIN SATURATION, ASTHMA AND CHEST CRISIS IN PAEDIATRIC SICKLE CELL. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 404-404.
Hogan AM, Telfer P, Prengler M, Saunders D, Wade AM, Vargha-Khadem F, Kirkham FJ (2008). Intellectual function in children with sickle cell anemia: longitudinal data from the East London cohort. BRITISH JOURNAL OF HAEMATOLOGY. vol. 141, 111-111.
Marshall MJ, Laverty A, Dingle-Gavlak J, Kirkham FJ, Evans J, Telfer P, Wilkey O, Yardumian A et al. (2008). Sleep-related breathing disorders in sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 141, 112-112.
Alexander E, Telfer P, Rashid H, Ali KA, Booy R(2008). Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine. J Infect Public Health vol. 1, (1) 40-44.
10.1016/j.jiph.2008.08.005
Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, Smalling B, Amos R et al.(2007). Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica vol. 92, (7) 905-912.
10.3324/haematol.10937
Hogan AM, Hill CM, Bucks R, Telfer P, Kirkham FJ(2007). Increased cerebral blood flow velocity in children with sickle cell disease: Adenotonsillectomy or transfusion regimens? In reply. PEDIATRICS vol. 120, (1) 236-237.
10.1542/peds.2007-1121
Anderson AK, Simmons A, Newell H, Fofana N, Paterson M, Telfer P (2007). Avascular necrosis of the femoral head in HbSS children taking hydroxyurea. BRITISH JOURNAL OF HAEMATOLOGY. vol. 137, 73-73.
Lahoz C, Ali K, Challands J, Morrison I, Newell K, John Y, Telfer P (2007). Evaluation of analgesia regime with intranasal diamorphine and oral morphine for acute painful sickle crises in children. BRITISH JOURNAL OF HAEMATOLOGY. vol. 137, 82-83.
Bhattacharya A, Newell H, Evanson J, Kirkham F, Telfer P (2007). Extracranial carotid artery occlusion in children with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 137, 73-73.
Telfer P, Franklin A, Carr S, McKenzie S, Newell H, Kirkham F (2007). Nocturnal hypoxaemia is associated with conditional and high risk transcranial doppler velocities in children with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 137, 88-88.
Hogan AM, Telfer P, Kirkham FJ (2007). The impact of infection in early childhood on intellectual function in adolescence: evidence from children with sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY. vol. 137, 29-29.
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M et al.(2006). Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica vol. 91, (9) 1187-1192.
Yakout TI, Beski S, Telfer P (2006). Anaemia in pregnancy at the Royal London Hospital. BRITISH JOURNAL OF HAEMATOLOGY. vol. 133, 35-36.
Baldeweg T, Hogan AM, Saunders DE, Telfer P, Gadian DG, Vargha-Khadem F, Kirkham FJ(2006). Detecting white matter injury in sickle cell disease using voxel-based morphometry. ANN NEUROL vol. 59, (4) 662-672.
10.1002/ana.20790
Lusher J, Elander J, Bevan D, Fer PT, Burton B(2006). Analgesic addiction and pseudoaddiction in painful chronic illness. CLIN J PAIN vol. 22, (3) 316-324.
10.1097/01.ajp.0000176360.94644.41
TELFER PT, Prengler M, Hogan A, Kirkham F, de Haan M, Vargha-Khadem F, Lane R(2006). An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anemia. British Journal of Haematology. vol. 132, 99-107.
10.1111/j.1365-2141.2005.05828.x
Baldeweg T, Hogan AM, Saunders DE, Telfer P, Gadian DG, Vargha-Khadem F, Kirkham FJ(2006). White matter injury in children with sickle cell disease detected using voxel-based morphometry. DEV MED CHILD NEUROL vol. 48, 13-13.
TELFER PT, Kirkham F, Hogan A, Saunders D, Baldeweg T, Vargha-Khadem F, Gadian D(2006). White matter injury in children with sickle cell disease detected using voxel-based morphometry. Ann Neurol. vol. 59, 662-672.
New HV, Cale CM, Tischkowitz M, Jones A, Telfer P, Veys P, D'Andrea A, Mathew CG et al.(2005). Nijmegen breakage syndrome diagnosed as Fanconi anaemia. PEDIATR BLOOD CANCER vol. 44, (5) 494-499.
10.1002/pbc.20271
Lehal R, Davies C, Morrison I, Newell K, John Y, Mackay L, Challands J, Telfer P (2005). Evaluation of intranasal diamorphine together with oral morphine for management of acute sickle pain in children. BRITISH JOURNAL OF HAEMATOLOGY. vol. 129, 73-73.
Telfer PT, Coen P, Chakravorty S, Wilkey O, Newell K, Evans J, Kirkham F (2005). Survival and neurological complications in children with sickle cell disorders: data from an East London neonatal cohort. BRITISH JOURNAL OF HAEMATOLOGY. vol. 129, 83-83.
Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M (2005). Quality of life in thalassemia. COOLEY'S ANEMIA EIGHTH SYMPOSIUM. Editors: Vichinsky, EP, vol. 1054, 273-282.
10.1196/annals.1345.035
Chakravorty S, Newell K, Ramchandani J, Qureshi K, Ibrahim R, Datta B, Telfer PT(2004). Sickle cell disease pain in London and the Caribbean. Arch Dis Child vol. 89, (3) 272-273.
10.1136/adc.2002.020073
Elander J, Lusher J, Bevan D, Telfer P, Burton B(2004). Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J PAIN SYMPTOM MANAG vol. 27, (2) 156-169.
10.1016/j.jpainsymman.2003.12.001
Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M(2003). Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol vol. 25, (3) 195-197.
10.1046/j.1365-2257.2003.00508.x
Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J(2003). Guidelines for the management of the acute painful crisis in sickle cell disease. BRIT J HAEMATOL vol. 120, (5) 744-752.
10.1046/j.1365-2141.2003.04193.x
TELFER PT, Bevan D, Lusher J, Elander J(2003). Pain managaement and symptoms of substance dependence among patients with sickle cell disease. Social Sciences and Medicine vol. 57, 1683-1696.
10.1016/s0277-9536(02)00553-1
Gupta V, Bremner FD, Telfer P(2001). Bilateral retinal haemorrhages: an unusual presentation of pernicious anaemia. Br J Haematol vol. 112, (4)
10.1046/j.1365-2141.2001.02689.x
TELFER PT, Pearson TC, Doughty H, Win N, Wild BJ(2001). Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion vol. 41, 323-328.
10.1046/j.1537-2995.2001.41030323.x
Kottaridis PD, Peggs K, Lawrence A, Verfuerth S, Chatterjee R, Telfer P, Porter JB, Mackinnon S et al.(2000). One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and β-thalassaemia major: Potential cure of both marrow disorders. Bone Marrow Transplantation vol. 25, (6) 677-678.
10.1038/sj.bmt.1702213
Return to top